Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer
Direct links to NCBI, no account and no request form: the whole study as GSE311373_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 5 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA1369365 and SRA study SRP648831. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 5 more — browse all 5 samples with per-sample file links →
- GSE250056 Targeting chemokine crosstalk between T-cells and macrophages to treat immune checkpoint inhibito-mediated myocarditis 68 samples
- GSE327213 Increased mRNA translation delays tumor initiation and exposes a therapeutic vulnerability in lung cancer 16 samples
- GSE304864 Multiomics immune profiling of a patient-relevant orthotopic lung cancer model using SEPARATE-Seq. 11 samples
- GSE314584 Toll-Like-Receptor 5 Reduces Lung Dysbiosis and Protects Against Pulmonary Fibrosis 124 samples
- GSE269045 Inflammatory immune modulators of AML lung infiltration and respiratory failure 56 samples
- GSE326797 Antibody Mediated Diversification of Primary and Secondary Humoral Immune Responses 54 samples
- GSE296466 PU.1 is a mediator of the reactive stroma response associated with castration-resistant prostate cancer 46 samples
- GSE270050 Expansion of Tumor-Infiltrating CD8+ T Cell Clonotypes Occurs in the Spleen in Response to Immune Checkpoint Blockade 29 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.